News & Events CTI CEO to Speak on Cancer, Care and Community Panel

CTI CEO to Speak on Cancer, Care and Community Panel

June 18, 2018

FOR IMMEDIATE RELEASE [Covington, KY ~ June 18, 2018] Timothy Schroeder, CEO of CTI Clinical Trial and Consulting Services (CTI), will be a panelist at "Eggs 'N Issues: Cancer, Care and Community," on Tuesday, June 19. The event will be an in-depth discussion hosted by the NKY Chamber of Commerce as a part of their regular Eggs 'N Issues series.

"I am honored to have been invited to be a part of this panel, and I am looking forward to the discussion," remarks Schroeder. "Nearly a quarter of CTI's projects currently involve oncology, and our teams are working hard to help further innovations in cancer research. There have been so many advances happening in oncology recently, and it is important to continue the conversation and continue the momentum in developing new life-changing treatments."

Schroeder will be joined on the panel by Dr. Douglas Flora from St. Elizabeth Healthcare, and Dr. Ray Takigiku of Bexion Pharmaceuticals.

The event will be held at  Receptions Banquet And Conference Center - South at 1379 Donaldson Road, Erlanger, KY 41018. Pre-registration is required. For more information about the event and how to register, click here.

About CTI Clinical Trial and Consulting Services

CTI Clinical Trial and Consulting Services is a global, privately held, full-service contract research organization (CRO), delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine/gene therapy, immunology, transplantation, nephrology, hematology/oncology, neurology, infectious diseases, hepatology, cardiopulmonary, and pediatric populations. CTI also offers a fully integrated multi-specialty clinical research site that conducts phase I-IV trials. CTI has a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. With clinical trial experience across 6 continents, CTI partners with research sites, patients, and sponsors to fulfill unmet medical needs. CTI is headquartered in the Greater Cincinnati, OH area, with operations across North America, Europe, Latin America, and Asia-Pacific. For more information visit

Subscribe to our mailing list

* indicates required